Jon C. Bates's most recent trade in Nutex Health Inc was a trade of 2,667 Common Stock done . Disclosure was reported to the exchange on March 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2026 | 2,667 | 8,305 | - | 0 | Common Stock | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2026 | 1,694 | 5,527 | - | - | Restricted Stock Units | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 136.71 per share. | 25 Nov 2025 | 750 | 5,638 | - | 136.7 | 102,532 | Common Stock |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 3,500 | 6,500 | - | - | Restricted Stock Units | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 1,500 | 3,888 | - | 0 | Common Stock | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 81.81 per share. | 01 Mar 2025 | 1,000 | 4,888 | - | 81.8 | 81,810 | Common Stock |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 111 | 2,388 | - | 0 | Common Stock | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 21.46 per share. | 22 Aug 2024 | 1,350 | 2,277 | - | 21.5 | 28,970 | Common Stock |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 45,000 | 48,301 | - | - | Restricted Stock Unit | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2024 | 49,505 | 139,010 | - | - | Common Stock | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2024 | 49,505 | 49,505 | - | - | Restricted Stock Units | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.42 per share. | 15 Jun 2023 | 20,000 | 89,505 | - | 0.4 | 8,346 | Common Stock |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 148,515 | 148,515 | - | - | Restricted Stock Unit | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 49,505 | 49,505 | - | 0 | Common Stock | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 49,505 | 99,010 | - | - | Restricted Stock Unit | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 20,000 | 69,505 | - | 0 | Common Stock | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 20,000 | 0 | - | - | Restricted Stock Unit | |
| Nutex Health Inc | Jon C. Bates | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 20,000 | 20,000 | - | - | Restricted Stock Unit |